Search here for business resources using multiple criteria on the right side bar.
The North Carolina Biotechnology Center understands the importance of emerging entrepreneurial companies to the state’s biotechnology industry. Through the Business and Technology Development Program, the Center awards low-interest loans to promising emerging life science companies across the state. These loans are designed to help recipients meet meaningful research and commercial milestones.
NCBC connects the company and university researchers; the funders and the small companies; the job seekers and job providers. We provide funding when few others do. We keep an eye on emerging biotech sectors. And we make sure North Carolina leads the way.
Mark Phillips is responsible for directing and promoting biotechnology-related growth and development activities for the Biotechnology Center’s Eastern Office in Greenville. Phillips serves as the regions’ contact to the Biotechnology Center’s grant and loan funding programs, while working with companies, schools and institutions throughout a 27-county region to strengthen biotechnology research, business, education and workforce training, and to identify new opportunities for commercial biotechnology
NCBiotech research grant programs are designed to encourage innovation, support university infrastructure and help move technology toward commercialization. In addition, our grants fill in some critical funding gaps, stages where it is typically difficult to find funding.
We’re well known for making connections that create biotech jobs statewide. But we also offer two popular funding programs to make sure people with big ideas mix and mingle.
Our event sponsorships, for example, provide up to $3,000 to help bring biotech people together within North Carolina.
Meanwhile, our meeting grants provide non-profits up to $10,000 to help them bring major life science meetings to the state. Bringing in thought leaders from across the U.S. and around the globe puts a great spotlight on North Carolina and its life science leadership.